Lorazepam EP Impurity C CAS 2955-37-5
| CAS No. | 2955-37-5 |
| Molecular Formula | C15H10Cl2N2O2 |
| Molecular Weight | 321.16 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
As a process- or degradation-related impurity, Lorazepam EP Impurity C (CAS 2955-37-5, C15H10Cl2N2O2) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Lorazepam EP Impurity C (C15H10Cl2N2O2) contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, chlorine substitution. It is notably hygroscopic, halogen substitution raises its density and boiling point, its high carbon-to-hydrogen ratio confers good lipid solubility, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Lorazepam EP Impurity C under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C15H10Cl2N2O2 |
| Molecular Weight | 321.16 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 11.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1957 |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 2 |
Related Lorazepam Standards
Recommended Standards
- N-Benzyl 5-borono-2-methoxybenzenesulfonamide (CAS 874219-51-9)
- 3-Bromo-5-((4-methoxybenzyl)oxy)benzaldehyde (CAS 1068604-40-9)
- N-(2-Cyanophenyl)-2-(2,4-dichlorophenoxy)acetamide (CAS 306316-35-8)
- 4-Bromo-2-(4-methoxybenzyloxy)-benzaldehyde (CAS 1099608-97-5)
- Mirogabalin impurity 169 (CAS 2007951-40-6)
- Orlistat Impurity 47 (CAS CATO-C4X-149947)
- Troxipide Impurity 25 (CAS 31648-51-8)
- Dimethyltetrahydrofolic Acid (CAS CATO-C4X-139530)
- 3-(1H-Indol-3-yl)-1-[3-(trifluoromethyl)phenyl]pyrrolidine-2,5-dione (CAS 338962-75-7)
- 3-(2-Methoxyphenoxy)pyrrolidine hydrochloride (CAS 17741-15-0)
- Ethyl (E)-3-((5S,8aS)-5-benzyl-3-oxodihydro-1H,3H-oxazolo[4,3-c][1,4]oxazin-8a(8H)-yl)acrylate (CAS 1556097-90-5)
- Sodium benzene-1,2,4,5-tetracarboxylate (CAS 148-04-9)
- (2-{4-chloropyrrolo[2,1-f][1,2,4]triazin-7-yl}ethyl)(methyl)amine (CAS 1546680-42-5)
- D-[γ-Glu](Side Chain)-Semaglutide (CAS CATO-C4X-2226254)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com